Awad AlQahtani1, Armen Parsyan2, Richard Payne3, Roger Tabah4. 1. The Division of Surgical Oncology, McGill University, Montréal, Que., and the Division of General Surgery, King Saud University, Riyadh, Saudi Arabia. 2. The Division of General Surgery, McGill University, Montréal, Que. 3. The Department of Otolaryngology, McGill University, Montréal, Que. 4. The Division of Surgical Oncology, and the Division of General Surgery, McGill University, Montréal, Que.
Abstract
BACKGROUND: Parathyroid dysfunction leading to symptomatic hypocalcemia is not uncommon following a total or completion thyroidectomy and is often associated with significant patient morbidity and a prolonged hospital stay. A simple, reliable indicator to identify patients at risk would permit earlier pharmacologic prophylaxis to avoid these adverse outcomes. We examined the role of intact parathormone (PTH) levels 1 hour after surgery as a predictor of post-thyroidectomy hypocalcemia. METHODS: We prospectively reviewed the cases of consecutive patients undergoing total or completion thyroidectomy. Ionized calcium (Ca(2+)) and intact PTH levels were measured preoperatively and at 1-, 6- and 24-hour intervals postoperatively. The specificity, sensitivity, negative and positive predictive values of the 1-hour PTH serum levels (PTH-1) in predicting 24-hour post-thyroidectomy hypocalcemia and eucalcemia were determined. RESULTS: We reviewed the cases of 149 patients. Biochemical hypocalcaemia (Ca(2+) < 1.1 mmol/L) developed in 38 of 149 (25.7%) patients 24 hours after thyroidectomy. The sensitivity, specificity, positive and negative predictive values of a low PTH-1 were 89%, 100%, 97% and 100%, respectively. CONCLUSION: We found that PTH-1 levels were predictive of symptomatic hypocalcemia 24 hours after thyroidectomy. Routine use of this assay should be considered, as it could prompt the early administration of calcitriol in patients at risk of hypocalcemia and allow for the safe and timely discharge of patients expected to remain eucalcemic.
BACKGROUND:Parathyroid dysfunction leading to symptomatic hypocalcemia is not uncommon following a total or completion thyroidectomy and is often associated with significant patient morbidity and a prolonged hospital stay. A simple, reliable indicator to identify patients at risk would permit earlier pharmacologic prophylaxis to avoid these adverse outcomes. We examined the role of intact parathormone (PTH) levels 1 hour after surgery as a predictor of post-thyroidectomy hypocalcemia. METHODS: We prospectively reviewed the cases of consecutive patients undergoing total or completion thyroidectomy. Ionizedcalcium (Ca(2+)) and intact PTH levels were measured preoperatively and at 1-, 6- and 24-hour intervals postoperatively. The specificity, sensitivity, negative and positive predictive values of the 1-hour PTH serum levels (PTH-1) in predicting 24-hour post-thyroidectomy hypocalcemia and eucalcemia were determined. RESULTS: We reviewed the cases of 149 patients. Biochemical hypocalcaemia (Ca(2+) < 1.1 mmol/L) developed in 38 of 149 (25.7%) patients 24 hours after thyroidectomy. The sensitivity, specificity, positive and negative predictive values of a low PTH-1 were 89%, 100%, 97% and 100%, respectively. CONCLUSION: We found that PTH-1 levels were predictive of symptomatic hypocalcemia 24 hours after thyroidectomy. Routine use of this assay should be considered, as it could prompt the early administration of calcitriol in patients at risk of hypocalcemia and allow for the safe and timely discharge of patients expected to remain eucalcemic.
Authors: Oliver Thomusch; Andreas Machens; Carsten Sekulla; Jörg Ukkat; Michael Brauckhoff; Henning Dralle Journal: Surgery Date: 2003-02 Impact factor: 3.982
Authors: F Pattou; F Combemale; S Fabre; B Carnaille; M Decoulx; J L Wemeau; A Racadot; C Proye Journal: World J Surg Date: 1998-07 Impact factor: 3.352
Authors: Celestino Pio Lombardi; Marco Raffaelli; Pietro Princi; Stefano Santini; Mauro Boscherini; Carmela De Crea; Emanuela Traini; Anna Maria D'Amore; Cinzia Carrozza; Cecilia Zuppi; Rocco Bellantone Journal: Surgery Date: 2004-12 Impact factor: 3.982
Authors: Kevin M Higgins; David L Mandell; Satish Govindaraj; Eric M Genden; Jeffrey I Mechanick; Donald A Bergman; Edward J Diamond; Mark L Urken Journal: Arch Otolaryngol Head Neck Surg Date: 2004-01
Authors: James E Wiseman; Matthew Mossanen; Philip H G Ituarte; Jonathan M T Bath; Michael W Yeh Journal: World J Surg Date: 2010-03 Impact factor: 3.352
Authors: F Tartaglia; A Giuliani; S Sorrenti; L Tromba; S Carbotta; A Maturo; G Carbotta; L De Anna; R Merola; G Livadoti; F Pelle; S Ulisse Journal: G Chir Date: 2016 Nov-Dec
Authors: F Schlottmann; A L Campos Arbulú; E E Sadava; P Mendez; L Pereyra; J M Fernández Vila; N A Mezzadri Journal: Langenbecks Arch Surg Date: 2015-09-11 Impact factor: 3.445
Authors: S Mattoo; A Agarwal; S Mayilvaganan; P Mishra; G Agarwal; A Mishra; G Chand; S K Gupta; S K Mishra Journal: J Endocrinol Invest Date: 2021-01-27 Impact factor: 4.256
Authors: Sumiya Jaan; Ashish Sehgal; Rauf Ahmad Wani; Muneer Ahmad Wani; Khursheed Alam Wani; Bashir Ahmad Laway Journal: Indian J Endocrinol Metab Date: 2017 Jan-Feb